Company Profile - Viridian Therapeutics Inc
Introduction
Viridian Therapeutics Inc (Viridian), formerly Miragen Therapeutics Inc is a clinical stage biopharmaceutical company. The company discovers and develops novel RNA-based therapeutics, with a core focus on therapeutic antibodies and their roles in diseases. It focuses on thyroid eye disease and cardiovascular disease areas. Viridian lead pipeline products candidates include VRDN-001 (Intravenous) for treating thyroid eye disease (TED); and VRDN-002 (Subcutaneous), an inhibitor using half-life technology for treating thyroid eye disease (TED). The company has been depending on the third parties for the manufacturing and supply of the products. Viridian is headquartered in Boulder, Colorado, the US.
Company info
| Country (HQ): | United States |
| Sector: | Medical Equipment |
| Market Cap (US$ m): | 988 |
| Revenue (US$ m): | 2 (2022) |
Innovation ranking
Innovation score
Closest peers in the Medical Equipment sector
Innovation Ranking
Medtronic Plc
Ireland
Medical Equipment
Boston Scientific Corp
United States
Medical Equipment
Viridian Therapeutics Inc
United States
Medical Equipment
Savara Inc
United States
Medical Equipment
Aethlon Medical Inc
United States
Medical Equipment
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release
